© 2022 MJH Life Sciences and Urology Times. All rights reserved.
© 2022 MJH Life Sciences™ and Urology Times. All rights reserved.
September 15, 2021
Multiple PSMA-PET imaging agents are approved by the FDA for use in prostate cancer.
August 27, 2021
Urology areas covered for this FDA clearance include conditions of the prostate, bladder, kidneys, and genitalia.
August 10, 2021
The SAP program cultivates a community of advocacy groups, medical associations, and medical institutions to foster collaboration and an open exchange of information among trusted peers for the ultimate benefit of patients and their families.
July 21, 2021
The noninvasive UriFind test identifies bladder cancer based on methylation detection of exfoliated cell DNA in urine.
July 11, 2021
The federal agency has issued final guidance on how to design studies that include this patient population.
June 28, 2021
Questions remain surrounding the origin of the global pandemic.
June 18, 2021
Here are some news items in the urology field you may have missed this week.
June 17, 2021
Concepcion is editor-in-chief of Urology Times' sister publication, Urologists in Cancer Care.
June 16, 2021
Lantheus, the developer of piflufolastat F 18, selected oncology provider GenesisCare to administer the first commercially available dose of the agent.
June 01, 2021